Rheumatology Department, Coimbra University Hospital, Coimbra, Portugal.
Osteoporos Int. 2010 Jun;21(6):977-83. doi: 10.1007/s00198-009-1036-5. Epub 2009 Sep 2.
Clinicians need tools to identify patients most likely to benefit from bone mineral density (BMD) testing, for which cost-effectiveness does not allow generalized screening. This study supports the utility of osteoporosis risk assessment tools in selecting men for BMD testing. Different cutoff values may be appropriate for different countries and/or ethnic origins.
Our aim was to evaluate the utility of three osteoporosis (OP) risk assessment tools in a large group of Portuguese men aged 50 or more and to determine the best cutoff value to be used for selecting men for bone densitometry.
We assessed the performance of three simple tools in 202 randomly selected men: body weight criterion (BWC), osteoporosis self-assessment tool for Asians (OSTA), and a modified version of the OSTA equation (OST). Previously published cutoff values (validated in postmenopausal women) and three additional cutoff values were tested. Sensitivity (SE), specificity (SP), predictive values, and area under the receiver operating characteristic (AUROC) curve for correctly selecting men with OP (defined by BMD testing) were determined.
Mean age of the cohort was 63.8 years. According to the World Health Organization diagnostic categories, 16.8% had osteoporosis. The best performing cutoffs for correctly selecting men with OP for BMD testing were OST < 3 (SE = 75.5%, SP = 50.0%, AUROC = 0.632), OSTA < 3 (SE = 73.5%, SP = 58.3%, AUROC = 0.659), and BWC < 75 kg (SE = 73.5%, SP = 61.3%, AUROC = 0.674).
OP risk assessment tools seem to be useful in men aged 50 or more. Best cutoff values are different from those recommended for postmenopausal women. Different cutoff values may be appropriate for different countries and/or ethnic origins.
临床医生需要工具来识别最有可能从骨密度(BMD)测试中获益的患者,但成本效益不允许普遍筛查。本研究支持骨质疏松风险评估工具在选择男性进行 BMD 测试中的效用。不同的截止值可能适用于不同的国家和/或种族起源。
我们的目的是评估三种骨质疏松症(OP)风险评估工具在一大群年龄在 50 岁或以上的葡萄牙男性中的效用,并确定用于选择男性进行骨密度测定的最佳截止值。
我们评估了三种简单工具在 202 名随机选择的男性中的表现:体重标准(BWC)、亚洲人骨质疏松症自我评估工具(OSTA)和改良的 OSTA 方程(OST)。测试了以前发表的截止值(在绝经后妇女中验证)和另外三个截止值。确定了正确选择患有 OP(通过 BMD 测试定义)的男性的敏感性(SE)、特异性(SP)、预测值和接受者操作特征(ROC)曲线下面积(AUROC)。
队列的平均年龄为 63.8 岁。根据世界卫生组织的诊断类别,16.8%的人患有骨质疏松症。OST < 3(SE = 75.5%,SP = 50.0%,AUROC = 0.632)、OSTA < 3(SE = 73.5%,SP = 58.3%,AUROC = 0.659)和 BWC < 75 kg(SE = 73.5%,SP = 61.3%,AUROC = 0.674)的最佳截止值可正确选择接受 BMD 测试的男性患有 OP。
OP 风险评估工具似乎在 50 岁或以上的男性中有用。最佳截止值与绝经后妇女推荐的截止值不同。不同的截止值可能适用于不同的国家和/或种族起源。